Autolus Therapeutics plc — All Filings
296 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
20-F
20-F/A
3
424B3
424B4
424B5
6-K
6-K/A
8-A12B
8-K
8-K/A
CERT
CORRESP
CT ORDER
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
NT 10-Q
POS AM
POSASR
S-1
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| CORRESP | — | 0001193125-25-118795 | May 13, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-001441 | May 12, 2025 | — |
| UPLOAD | — | 0000000000-25-005022 | May 12, 2025 | — |
| 10-Q | 10-Q | 0001730463-25-000039 | May 8, 2025 | Mar 31, 2025 |
| S-1 | S-1 | 0001193125-25-116059 | May 8, 2025 | — |
| 8-K | 8-K | 0001730463-25-000032 | May 8, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-065100 | May 7, 2025 | — |
| 8-K | 8-K | 0001730463-25-000022 | Apr 23, 2025 | — |
| SCHEDULE 13G/A | — | 0000902219-25-000146 | Apr 4, 2025 | — |
| 8-K | 8-K | 0001193125-25-072356 | Apr 3, 2025 | Feb 28, 2025 |
| EFFECT | — | 9999999995-25-000726 | Mar 21, 2025 | — |
| 10-K | 10-K | 0001730463-25-000019 | Mar 20, 2025 | Dec 31, 2024 |
| POS AM | POS AM | 0001193125-25-059363 | Mar 20, 2025 | — |
| POSASR | POSASR | 0001193125-25-059188 | Mar 20, 2025 | — |
| 8-K | 8-K | 0001730463-25-000010 | Mar 20, 2025 | — |
| 8-K | 8-K | 0001730463-25-000004 | Jan 13, 2025 | — |
| S-8 | S-8 | 0001193125-24-258571 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-119023 | Nov 14, 2024 | — |
| SC 13G/A | — | 0001172661-24-004726 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-258350 | Nov 14, 2024 | — |
| 10-Q | 10-Q | 0001730463-24-000136 | Nov 12, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0001730463-24-000132 | Nov 12, 2024 | — |
| SC 13G | — | 0000315066-24-002670 | Nov 12, 2024 | — |
| 8-K | 8-K | 0001730463-24-000129 | Nov 12, 2024 | Nov 8, 2024 |
| SC 13G | SEC SCHEDULE 13G | 0000902219-24-000455 | Nov 8, 2024 | — |
| UPLOAD | — | 0000000000-24-012382 | Nov 7, 2024 | — |
| SC 13D/A | AMENDMENT NO. 10 TO SCHEDULE 13D | 0001213900-24-090768 | Oct 25, 2024 | — |
| CORRESP | — | 0001730463-24-000121 | Sep 30, 2024 | — |
| 8-K | 8-K | 0001730463-24-000110 | Sep 26, 2024 | — |
| UPLOAD | — | 0000000000-24-010662 | Sep 19, 2024 | — |
| 8-K | 8-K | 0001730463-24-000104 | Sep 19, 2024 | Sep 13, 2024 |
| 144 | — | 0001968582-24-000830 | Sep 16, 2024 | — |
| 8-K | 8-K | 0001730463-24-000099 | Sep 13, 2024 | Sep 10, 2024 |
| 10-Q | 10-Q | 0001730463-24-000093 | Aug 8, 2024 | Jun 30, 2024 |
| 8-K | 8-K | 0001730463-24-000088 | Aug 8, 2024 | — |
| 8-K | 8-K | 0001730463-24-000076 | Jun 28, 2024 | — |
| 8-K | 8-K | 0001730463-24-000074 | Jun 5, 2024 | — |
| 8-K | 8-K | 0001730463-24-000070 | Jun 3, 2024 | May 31, 2024 |
| 10-Q | 10-Q | 0001730463-24-000064 | May 17, 2024 | Mar 31, 2024 |
| 8-K | 8-K | 0001730463-24-000059 | May 17, 2024 | — |
| 8-K | 8-K | 0001193125-24-136696 | May 13, 2024 | — |
| NT 10-Q | NT 10-Q | 0001730463-24-000052 | May 13, 2024 | — |
| 8-K | 8-K | 0001730463-24-000050 | Apr 1, 2024 | Mar 26, 2024 |
| S-3ASR | S-3ASR | 0001193125-24-080609 | Mar 28, 2024 | — |
| SC 13D/A | AMENDMENT NO. 9 TO SCHEDULE 13D | 0001213900-24-025536 | Mar 25, 2024 | — |
| 8-K | 8-K | 0001730463-24-000045 | Mar 21, 2024 | — |
| 10-K | 10-K | 0001730463-24-000048 | Mar 21, 2024 | Dec 31, 2023 |
| 8-K/A | 8-K/A | 0001730463-24-000029 | Mar 15, 2024 | Mar 14, 2024 |
| 8-K | 8-K | 0001730463-24-000021 | Mar 14, 2024 | — |
| D | — | 0000950123-24-002720 | Feb 23, 2024 | — |